20 Mar 2025
CPMS 2.0 training for clinicians from 12th March 2025 onwards!
Dear user of the CPMS 2.0, With the migration of all data from the old…
Three new positions open at the University of Cambridge Mitochondrial Research Team
Join a world-class team led by Patrick Chinnery and Rita Horvath dedicated to mitochondrial diseases…
Peripheral Nerve Imaging with focus on Inflammatory Neuropathies
…TIMESLOT: Thursday, 20 March 2025 16:00 CET …MAIN TITLE: Peripheral Nerve Imaging with Focus on Inflammatory…
2nd edition of our Summer School on Multidisciplinary Management of NMDs!
We are delighted to announce the second edition of this Summer School, co-organized by…
Exploring Dysimmune and Inflammatory Neuropathies
The ERN EURO-NMD Working Group on Peripheral Nerve Diseases is pleased to present a Webinar…
Registry Onboarding is ongoing
Registry Onboarding is ongoing The ERN EURO-NMD Registry Hub intends to collect data from the…
ERN EURO-NMD: "Breaking barriers and building bridges in rare Neuromuscular Diseases"
What is an European Reference Network?
To review a patient’s diagnosis and treatment, ERN coordinators convene ‘virtual’ advisory boards of medical specialists across different disciplines, using a dedicated IT platform and telemedicine tools.
ERNs offer the potential to give patients and doctors across the EU access to the best expertise and timely exchange of life-saving knowledge,...
About EURO-NMD
EURO-NMD is a European Reference Network for the thematic grouping of rare neuromuscular diseases (NMDs), a broad group of related disorders that represent a major cause of mortality and lifelong disability in children and adults. NMDs are caused by acquired or genetic defects of motorneurons, peripheral nerves, neuromuscular junctions or...
Relevant resources at a distance of a click
Several essential resources support the EURO-NMD network, some supplied by the European Commission and others developed in-house. The objective is to fulfil the ERN’s goals of providing streamlined diagnostic and therapeutic features to support patient care across Europe and propel research in neuromuscular disorders.